Chief Scientific and Operating Officer Dr. Ryan Phan resigns effective Sep 15, 2023

Aspira Women's Health Inc.

Dr. Ryan Phan resigns as Chief Scientific and Operating Officer effective September 15, 2023.
Company expects to enter into an advisory agreement with Dr. Phan for ongoing product development.
No successor has been announced for the CSO and COO role.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Ryan Phan

Chief Scientific and Operating Officer

AWHL · Aspira Women's Health Inc.

Effective: 2023-09-15
Filed: August 9, 2023, 7:59 PM ET

On August 3, 2023, Dr. Ryan Phan notified Aspira Women’s Health Inc., (the “Company”), of his intent to resign as Chief Scientific and Operating Officer of the Company effective September 15, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Ryan Phan resigned as Chief Scientific and Operating Officer at Aspira Women's Health Inc..

Action: resigned
Role: Chief Scientific and Operating Officer

Exact text from the filing

On August 3, 2023, Dr. Ryan Phan notified Aspira Women’s Health Inc., (the “Company”), of his intent to resign as Chief Scientific and Operating Officer of the Company effective September 15, 2023.

View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0000926617-23-000063

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.